Captura Biopharma is an emerging biotechnology company engaged in the development and commercialization of heavy metal chelators.
Captura Biopharma has raised $50.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in August 2021.
Captura Biopharma's investors include The Global Emerging Markets Group.
Captura Biopharma is headquartered in Little Rock, United States.
Captura Biopharma is an emerging biotechnology company engaged in the development and commercialization of heavy metal chelators.
Captura Biopharma is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Captura Biopharma — Funding & Investors." VCBacked, August 18, 2021, https://www.vcbacked.co/company/captura-biopharma. Accessed August 14, 2026.
VCBacked. (2021). Captura Biopharma — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/captura-biopharma
{{cite web |title=Captura Biopharma — Funding & Investors |url=https://www.vcbacked.co/company/captura-biopharma |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated